SELECT Trial and Implications for Population Health

Chiadi Ndumele MD, MHS, Phd and Tiffany Powell-Wiley, MD, MPH discuss the results of the SELECT trial and the potential impact of the semaglutide as a treatment for obesity.
Follow us at @AHAScience and see full coverage of #AHA23 at professional.heart.org/en/mee...

[@b.a.d.2086]

HFpEF is probably most common in elderly women living on very modest means. Semaglutide costs more than many persons entire Social Security income.